Fabiola Martin

Summary

Affiliation: Hull York Medical School
Country: UK

Publications

  1. pmc Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, United Kingdom
    PLoS Negl Trop Dis 6:e1675. 2012
  2. pmc Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK
    Retrovirology 8:86. 2011

Detail Information

Publications2

  1. pmc Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, United Kingdom
    PLoS Negl Trop Dis 6:e1675. 2012
    ..We therefore tested the hypothesis that inhibition of T-cell activation with ciclosporin A would be safe and clinically beneficial in patients with early and/or clinically progressing HAM/TSP...
  2. pmc Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK
    Retrovirology 8:86. 2011
    ....